Videos

If you get a glioblastoma, you usually only have about 15 months to live.This malignant tumour spreads rapidly through the brain and unfortunately cannot be cured. Yanti De Visser is working on a personalised treatment to already slow down the brain tumour - with success. "The first results show that our approach has the potential to extend patients' lives by years, rather than months," she says.

One in 100 people suffer from a chronic heart condition. For example, their heart beats too fast even at rest, leaving these patients completely exhausted. Fortunately, surgery can help, but the procedure is risky and can lead to damage to the heart. To eliminate this risk, Rani Kronenberger (VUB) and her colleagues turn to 3D printing ...

Every 3 minutes, a woman dies of ovarian cancer somewhere in the world. "Ovarian cancer is very sneaky. Most of the patients respond positively to the therapies initially provided to them, but eventually, the cancer comes back and is much more aggressive. As a result one in two ovarian cancer patients die within 5 years after diagnosis." But what if we were able to treat ovarian cancer with a new therapy using our cells?

What if there might be a way to tackle the side effects of cancer treatments, such as fatigue, chronic pain and anxiety, even before the treatment begins? Kenza Mostaqim (VUB) introduces you to 'prehabilitation'.

Did you know that 20% of all healthcare expenses are 'waste'? "We are spending large sums of money on things that don't really improve patients' health, such as overtreatment, administrative efficiencies, and so on", says Joke Borzee. To treat our financially ill healthcare sector, she is working on a scoring model to assess the overall value of treatments. Watch her explain how this would work.

Why do people get cancer, arthritis, or Alzheimer's? Essentially because a protein key in our body does not fit in its respective lock. This is why Alvaro Martin is looking at removing defective keys and designing new protein keys. Keys that fit and can open the necessary locks, so that for example, our immune cells target and kill cancerous cells. "Protein design can be the key to unlocking a future without diseases."

Thanks to advanced proton therapy, doctors can precisely start irradiating brain tumours. Unfortunately, they do not yet dare to use this technique on tumours in the belly. Why? Because it's a bit like playing darts with a blindfold, while you have to hit a moving target, as Sophie Heymans explains in this video. She tells you about the technique she is working on to help doctors face this challenge.

Rats are our best friends. Or at least Emilie Bartsoen's. She only has to listen to her rats to know how they feel. By observing the social behaviour of rats, she also wants to help people with autism. How? She explains that to you in this video!

Do you ever wake up feeling like you have been run over by a truck? You are not alone. As many as 1 in 5 adults suffer from a sleep disorder, ranging from sleep apnoea to insomnia. With a compact, wearable device and AI, Elisabeth Heremans wants to analyse sleep problems in patients from the comfort of their own bed, instead of having them spend the night in a sleep clinic attached to a bunch of wires.

Up to 25% of the cells present in lung cancer tumours are currently ignored. As such, we don't know what the role of these so-called B cells is. "It is crucial to figure that out because we cannot efficiently fight something we do not fully understand," says Pauline Bardet (VUB - VIB - FWO).

In her PhD, she wants to get to the bottom of those B cells and thus find out whether those cells are "good guys" or "bad guys".

Roughly every 5 minutes someone on this planet dies of ALS, and the sad truth is that we still do not have an effective treatment to cure this disease. The problem lies in the fact that we do not fully understand what causes ALS in the first place. In his doctorate, Jimmy Beckers is trying to solve a piece of the puzzle. He is investigating whether a malfunction in our internal cellular recycling system might be linked to ALS.

Once diagnosed with glioblastoma, a highly aggressive brain cancer, a patient has on average only 15 months to live. "This terrible statistic shows that we urgently need new treatment options," says Myrthe Mampay (VUB - FWO). In her research, she is looking for one such new treatment based on immunotherapy, in which she wants to use patient stem cells to make macrophages that attack the tumour.